InvestorsHub Logo
Followers 39
Posts 13335
Boards Moderated 1
Alias Born 12/09/2015

Re: longtermgems post# 2348

Wednesday, 01/04/2017 1:55:07 PM

Wednesday, January 04, 2017 1:55:07 PM

Post# of 7900
SurgiBot will never make it to market
Senhance is a commercial failure in Europe and was not submitted for FDA approval by the end of 2016 as previously announced.
Lincoln Park Capital is a vulture and your stock is being further diluted.
Otherwise your looking good!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASXC News